Since both the inhibition and sustained activation of RAS signaling are related to a decrease in cell survival, we analyzed the viability of the CRC cell lines DLD-1 (expressing oncogenic KRAS) and DLD-1-KO (oncogenic KRAS allele deleted), and the non-transformed cell line hTERT-RPE. This evidence concerns the gene KRAS and colorectal carcinoma.